EODData

MEMBERSHIP REGISTER LOG IN

FRA, 9OF: BIORESTORAT.THERAP.DL-01

27 Mar 2026
LAST:

0.2520

CHANGE:
 0.00		OPEN:
0.3000		HIGH:
0.3000		ASK:
0.0000		VOLUME:
0
CHG(%):
1.61		PREV:
0.2480		LOW:
0.2500		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
27 Mar 260.30000.30000.25000.25200
26 Mar 260.26600.26600.24800.248018.1K
25 Mar 260.24600.26400.24600.264018.1K
24 Mar 260.26400.26400.25400.2540900
23 Mar 260.23200.28000.22800.2800900
20 Mar 260.21800.23400.21600.234021.0K
19 Mar 260.20200.20200.19900.20000
18 Mar 260.20400.21000.20400.21000
17 Mar 260.23600.24200.23000.23000
16 Mar 260.24800.26000.24600.26000

PROFILE

Name:BIORESTORAT.THERAP.DL-01
About:BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. It develops programs relate to the treatment of disc/spine disease and metabolic disorders. The company's products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. It also operates a commercial biocosmeceutical platform. In addition, the company provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is headquartered in Melville, New York.
Sector:Healthcare
Industry:Biotechnology
Address:40 Marcus Drive, Melville, NY, United States, 11747
Website:https://www.biorestorative.com
ISIN:US0906556065

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-0.83 
PEG Ratio:-0.01 
Price to Sales:22.82 
Price to Book:4.11 
Profit Margin:0.93 
Operating Margin:-314.32 
Return on Assets:-0.90 
Return on Equity:-2.08 
Revenue:325.7K 
Shares:7.98M 
Market Cap:2.01M 

TECHNICAL INDICATORS

MA5:0.263.0%
MA10:0.243.6%
MA20:0.2212.7%
MA50:0.4994.6%
MA100:0.75195.9%
MA200:1.02304.6%
STO9:52.00
STO14:40.00
RSI14:60.52 
WPR14:-35.00
MTM14:0.02
ROC14:0.10 
ATR:0.04 
Week High:0.3019.0%
Week Low:0.2216.7%
Month High:0.3331.0%
Month Low:0.17304.6%
Year High:1.69570.6%
Year Low:0.1656.5%